Group One Trading
TNYA icon

Group One Trading’s Tenaya Therapeutics TNYA Stock Holding History

Group One Trading’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$211K Buy
304,600
+22,700
+8% +$16.8K ﹤0.01% 4068
2025
Q4 		$201K Buy
281,900
+198,400
+238% +$270K ﹤0.01% 4365
2025
Q3 		$135K Sell
83,500
-38,500
-32% -$38.8K ﹤0.01% 5058
2025
Q2 		$74.6K Sell
122,000
-12,600
-9% -$6.41K ﹤0.01% 5235
2025
Q1 		$76.7K Buy
134,600
+128,700
+2,181% +$127K ﹤0.01% 4820
2024
Q4 		$8.44K Sell
5,900
-4,000
-40% -$8.97K ﹤0.01% 6185
2024
Q3 		$19.1K Buy
+9,900
New +$27.9K ﹤0.01% 5256
2024
Q2 		– Sell
-1,800
Closed -$9.41K – 7492
2024
Q1 		$9.41K Sell
1,800
-1,300
-42% -$6.22K ﹤0.01% 5900
2023
Q4 		$10K Sell
3,100
-100
-3% -$216 ﹤0.01% 6197
2023
Q3 		$8.16K Sell
3,200
-4,900
-60% -$20.5K ﹤0.01% 6465
2023
Q2 		$47.5K Buy
8,100
+3,100
+62% +$18K ﹤0.01% 5317
2023
Q1 		$14.3K Buy
+5,000
New +$14.1K ﹤0.01% 5743

Other funds holding TNYA

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
EAM
Empery Asset Management New York $83M AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BGM
Burkehill Global Management New York $2.02B AUM 85.32% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $141M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Group One Trading's TNYA Position: Q1 2026 in Review

Group One Trading increased its Tenaya Therapeutics (TNYA) stake by 141% in Q1 2026, buying an estimated $9.93K and bringing the position to 22,961 shares worth $15.9K. The position accounts for ﹤0.01% of the portfolio, ranked #6101.

Group One Trading first reported a position in TNYA in Q3 2022 and has held it in 7 quarters since. The position peaked at $53K in Q3 2025. 103 funds tracked by Wall St. Rank hold TNYA as of Q1 2026.

  • Group One Trading held 22,961 shares of Tenaya Therapeutics worth $15.9K as of Q1 2026.
  • Group One Trading bought 13,453 Tenaya Therapeutics shares in Q1 2026, an estimated $9.93K.
  • Tenaya Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #6101 holding.
  • Group One Trading first reported a position in Tenaya Therapeutics in Q3 2022 and has held it in 7 quarters since.
  • Group One Trading's Tenaya Therapeutics position peaked at $53K in Q3 2025.
  • 103 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.